Skip to main content

Finepoint Capital LP

SEC CIK
0001608126
Latest filing
Aug 13, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of RARE by Finepoint Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−203,200−100.0%Sold outHolders
Q2 2022203,200$12.1M4.2%+203,200NewHolders